These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 13816889)
1. [Pathogenetic and clinical observations on the use of hyoscine-N-butyl-bromide in asthma attacks]. DIOGUARDI N; SECCHI GC Dtsch Med J; 1959 Dec; 10():599-601. PubMed ID: 13816889 [No Abstract] [Full Text] [Related]
2. [Pharmacological and clinical observations on the combination of N-butyl-bromide of hyoscine and phenyldimethyl-pyrazolone-methylamino-methanesulfonate of sodium (buscopan compositum)]. MARINO A; MURARO U Rass Int Clin Ter; 1959 Dec; 39():1333-56. PubMed ID: 14421164 [No Abstract] [Full Text] [Related]
3. [Study of hyoscine N-butyl bromide during labor]. GUIAVARC'H R Sem Hop Ther Paris; 1960 May; 36():442-7. PubMed ID: 13830116 [No Abstract] [Full Text] [Related]
4. [Use of N-butylhyoscine bromide (Buscopan) in digestive pathology]. MONGES H; LEGRE M Sem Hop Ther Paris; 1961 Jun; 37():542-4. PubMed ID: 14475380 [No Abstract] [Full Text] [Related]
5. Relative potency of the atropine-like effects of a new parasympatholytic drug, scopolamine-N-(cyclopropyl methyl) bromide and those of hyoscine-N-butyl bromide. Litta-Modignani R; Mazzolari M; Barantani E; Bertoli D; Vibelli C Curr Med Res Opin; 1977-1978; 5(4):333-40. PubMed ID: 343994 [TBL] [Abstract][Full Text] [Related]
6. [Effects of hyoscine-N-butyl bromide on electroencephalography and the neuromuscular junction]. Lu SM; Chen XY Zhongguo Yao Li Xue Bao; 1987 Jan; 8(1):26-30. PubMed ID: 2955655 [No Abstract] [Full Text] [Related]
7. [Clinical contribution to the study of hyoscine N-butylbromide (B 2011)]. FORET J; SIMILON A J Belge Urol; 1952 Dec; 21(2):55-8. PubMed ID: 13044763 [No Abstract] [Full Text] [Related]
8. [Absorption and urinary excretion of digoxin in the presence of hyoscine butyl bromide and sulpiride in healthy subjects]. Jiménez Alonso J; Castillo-Ferrando JR; Bolaños J; Jaimez L; Pérez Jiménez F Rev Esp Cardiol; 1983; 36(2):121-3. PubMed ID: 6622791 [No Abstract] [Full Text] [Related]
10. [The treatment of spastic states with hyoscine-N-butylbromide]. HARTMANN HG Z Arztl Fortbild (Jena); 1953 Aug; 47(15):541-3. PubMed ID: 13090960 [No Abstract] [Full Text] [Related]
11. The effectiveness of scopolamine N-methyl bromide (pamine bromide) in the treatment of bronchial asthma: a spirometric and clinical study. DANN S; BROWN FR; BAUTISTA IA; SPIELMAN AD; KUPPERMAN HS Ann Allergy; 1959; 17():562-75. PubMed ID: 13814029 [No Abstract] [Full Text] [Related]
12. [Studies on the pharmacologic effect and clinical use of hyoscine-N-butylbromide (buscopan)]. HEINKEL K Dtsch Z Verdau Stoffwechselkr; 1951 Jul; 11(4):180-95. PubMed ID: 14872696 [No Abstract] [Full Text] [Related]
13. [Clinical effect of the spasmolytic agent hyoscine N-butylbromide (buscopan) in so-called spastic bronchitis in infants]. GADEKE R Kinderarztl Prax; 1955 Nov; 23(11):486-92. PubMed ID: 13279076 [No Abstract] [Full Text] [Related]
14. Hyoscine butylbromide to relieve utero-tubal obstruction at hysterosalpingography. Alper MM; Garner PR; Spence JE Br J Radiol; 1985 Sep; 58(693):915. PubMed ID: 3842296 [No Abstract] [Full Text] [Related]